Hormone Replacement Therapy Tablet Franchise in Ahmedabad

Estradiol + Dydrogesterone Tablet Supplier in Mumbai

Women’s Health Tablet Distributor in Delhi

HRT Pharma Franchise in Bangalore

Smilepill DG Tablet Stockist in Hyderabad
Hormone Therapy Tablet Manufacturer & Exporter in Chandigarh

Home/Products /estradiol-0-5mg-dydrogesterone-2-5mg-tablet

Smilepill DG Tablet

Composition : Estradiol (0.5mg) + Dydrogesterone (2.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 28 Tablets

Price : ₹0/-

Smilepill DG Tablet contains Estradiol 0.5 mg and Dydrogesterone 2.5 mg, a combination therapy for hormone replacement in women.

Estradiol is a natural estrogen that helps in alleviating menopausal symptoms such as hot flashes, mood swings, and bone loss, while Dydrogesterone is a progestogen that supports endometrial health and prevents estrogen-induced endometrial hyperplasia. Together, they provide comprehensive relief for menopausal women and those with hormonal imbalance.

Clinically, Smilepill DG Tablet is ideal for women undergoing menopause, irregular cycles, or requiring HRT for hormonal deficiencies, ensuring symptom relief, hormonal balance, and improved quality of life.

From a business perspective, Smilepill DG Tablet strengthens the women’s health and hormone therapy segment, widely prescribed in gynecology clinics, hospitals, and women’s wellness centers, offering consistent demand, repeat prescriptions, and trusted clinical efficacy, making it a high-value addition for pharma partners.

Read More

About the Product

Smilepill DG Tablet contains Estradiol 0.5 mg and Dydrogesterone 2.5 mg, a combination therapy for hormone replacement in women.

Estradiol is a natural estrogen that helps in alleviating menopausal symptoms such as hot flashes, mood swings, and bone loss, while Dydrogesterone is a progestogen that supports endometrial health and prevents estrogen-induced endometrial hyperplasia. Together, they provide comprehensive relief for menopausal women and those with hormonal imbalance.

Clinically, Smilepill DG Tablet is ideal for women undergoing menopause, irregular cycles, or requiring HRT for hormonal deficiencies, ensuring symptom relief, hormonal balance, and improved quality of life.

From a business perspective, Smilepill DG Tablet strengthens the women’s health and hormone therapy segment, widely prescribed in gynecology clinics, hospitals, and women’s wellness centers, offering consistent demand, repeat prescriptions, and trusted clinical efficacy, making it a high-value addition for pharma partners.

Common side effects may include nausea, headache, breast tenderness, mild bloating, or mood changes. Rarely, thromboembolic events, allergic reactions, or abnormal uterine bleeding may occur.

Smilepill DG Tablet is indicated for hormone replacement therapy in women experiencing menopausal symptoms such as hot flashes, night sweats, mood swings, and vaginal dryness. It is also used to prevent estrogen deficiency-related osteoporosis and to regulate menstrual irregularities in certain cases, as prescribed by a physician.

Use Smilepill DG Tablet strictly as prescribed by a healthcare professional. Inform your doctor of any history of cardiovascular disease, liver disorders, or hormone-sensitive cancers. Do not use during pregnancy. Discontinue use and seek medical advice if unusual bleeding, severe headaches, or swelling in the legs occurs.

Store at room temperature (20°C to 25°C), away from moisture and light, and keep it out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation